Clinical research organization India
                                                                   Who We Are | Mission | Partners | Leadership Team | Operations Team | Board of Directors
                                                                   Overview | Site Feasibility | Regulatory | Our Network | PI and Site Selection | Site Management | MORE
                                                                                                                    What's New | Press Releases | Events
                                                                   ELS Locations | Join Investigator Network | Request Information | Careers
clinical trials india Welcome
 

Your success. That’s our commitment at Excel Life Sciences. Everything we do is built around leveraging our expertise and passion to ensure that your clinical trials are successful. As the leading Trial Management Organization in India and through our trusted partnerships worldwide, we have the capabilities and bandwidth to take on any project large or small. And with offices and executive leadership based in the United States, you can be sure that we’re available when you are. Excel Life Sciences mixes a customized consultative approach with industry-leading experience and know-how to get results. Specifically our team’s experience includes:

  • 125 years combined experience in Clinical Medicine, Pharmaceutical Medicine and Biometrics
  • 45 years of regulatory experience and top USA and India regulatory executive’s on the ELS advisory board
  • 225 successfully conducted clinical trials at over 500 sites
  • 120 IND approvals & 20+ NDA approvals in US, Europe & Asia
clinical trials india What's New at ELS

ELS President and Chief Medical Officar , Dr. Vijay Kumar, MD is world renown as an expert in Indian Clinical Research. This month , he will be Speaking on “Clinical Research in India, Looking Back to Look Ahead".

 
Latest News

FDA Considering Changes To Risky Drug Safeguards

Sanofi-Aventis (France) Board Said to Support Genzyme Corporation Bid of Up to $18.7 Billion

BioNJ Study: Biotech Employment Grew Despite Downturn

FDA Advisory Committee Recommends Approval of AstraZeneca PLC's Brilinta (Ticagrelor) for Acute Coronary Syndromes; Lifts Forecast Due to Ruling

Patients 'Could Grow New Joints', Columbia University, University of Missouri And Clemson University Study

Leap Forward In Efforts To Develop Treatments For Huntington's Disease, Buck Institute for Age Research Study

Super-Sizing A Cancer Drug Minimizes Side Effects, Harvard University And Massachusetts Institute of Technology (MIT) Study

Shionogi Inc. Announces FDA Approval of CUVPOSA for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions

Breaching the Blood-Brain Barrier To Create Powerful New Tools for Fighting Cancer, Rensselaer Polytechnic Institute Study

Alzheimer's Unlocked: New Keys To A Cure

An HPV Vaccine Cheap Enough for the Developing World? Could Be According to Duke University Researchers

Abbott Laboratories's SIMCOR(R) (Niacin Extended-Release/Simvastatin ) Receives FDA Approval for New Dosage Strengths

Allergan Inc. Eye Drug Wins EU OK For Fluid Buildup

Omeros Corporation Secures $40 Million Committed Equity Financing Facility

Aptuit, Inc. and Siena Biotech S.p.A. Announce Strategic Relationship in Italy; Takes Minor Slice of Italian R&D Operations

Isis Pharmaceuticals, Inc. Earns $5 Million Milestone Payment From GlaxoSmithKline for Designation of a Development Candidate to Treat an Undisclosed Rare and Serious Disease

Immunotherapy Shows Benefit in Prostate Cancer, Dana-Farber Cancer Institute Study

Test Predicts Novartis AG's Kinase Inhibitor Resistance in CML, Hokkaido University Study

CMP Therapeutics Appoints Dr. Neill Moray Mackenzie as CEO

Kangmei Pharma Invests $44 Million In 2 TCM Companies

CT Atlantic AG Announces Appointment of Michael Hocker To CEO

Grifols H1 Sales Meet Forecasts, Net Profit Misses

Celgene Earnings Top Expectations, Shares Jump

Eli Lilly and Company Loses Appeal in Gemzar Patent Case

Sanofi-Aventis (France) Q2 Net up 61 Percent

Wyeth and Waste Management Firm Face Eur 12 Million in Fines

Talecris Biotherapeutics Q2 Profit Beats Street

BioPharm Executive: Firing Slows, but Lilly Fans the Flames

Astellas Pharma Inc. to Pay $295 Million to Extend License of Regeneron Pharmaceuticals, Inc.'s VelocImmune(R) Antibody Technology Through 2023

Trius Therapeutics Set to go Public This Week

Pfizer Inc.'s Viagra Weighed by U.S. FDA for Children With Rare Lung Disorder

One Molecule, Many More Insulin-Producing Cells To Treat Diabetes, Says University of Pittsburgh School of Medicine Team

Allos Therapeutics, Inc.'s Cancer Drug, Folotyn Extends Lung Cancer Survival

New Proteins That Regulate Blood Pressure, Flow Discovered, University of Pittsburgh School of Medicine Study

GlaxoSmithKline to Change Way it Pays U.S. Drug Sales Reps

HemaQuest Raises $4M More, Boosting VC Round to $16M for Sickle Cell, Blood Disorders

Generex Biotechnology Corporation Provides Positive Update On Oral-Lyn(TM) Pivotal Phase III Trial

Bausch & Lomb Recall of PreserVision Eye Vitamin in the United States

Illumina, Inc. Acquires Helixis, Inc. for Up to $105M, To Get Small, Low-Cost Genetic Analysis Tool

Merck & Co., Inc. Pays Settlements in 3,468 Vioxx Cases

Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) Acquires RNA Delivery Assets of Novosom

Vascular-Targeted Photodynamic Therapy for Localized Prostate Cancer, NYU Langone Medical Center Study

UK's Recommends Roche Holding AG's MabThera For Leukemia

Tris Pharma, Inc. Announces Approval of First-Time Generic of Methylphenidate Hydrochloride Oral Solution With Six Months Exclusivity

Mylan Inc. Plans Eur 67 Million Solid-Dose Packaging Plant in Hungary

Dyax Corp. Posts Narrower-Than-Expected Q2 Loss

Alcohol Reduces the Severity of Rheumatoid Arthritis, University of Sheffield Study Finds

AstraZeneca PLC Bloodthinner, Brilinta Goes Before U.S. Experts Today

Sanofi-Aventis (France), GlaxoSmithKline Eyes Troubled Genzyme Corporation; Rebuffs Bid

Scientists Tap Into Antarctic Octopus Venom; Venom as Potential Resource For Drug Development, University of Melbourne Study

Socialising 'Helps You Live Longer', Brigham Young University Study

Morphine Blocks Tumor Growth, University of Minnesota Study

Protein Identified That Can Result in Fragile Bones, Medical College of Georgia Study

EMD Serono, Inc., Merck KGaA Says FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MS

US FDA Staff Mixed on AstraZeneca PLC Drug, Brilinta

Key Milestone Towards the Development of a New Clinically Useful Antibiotic, John Innes Centre Study

Toxicology Sinks Vernalis PLC, Biogen Idec, Inc. (Massachusetts)'s Parkinson's Drug

Extended Use of Anti-Clotting Drug Helps Some Bedridden Patients, Washington University School of Medicine Study Partially Funded By Sanofi-Aventis (France)

Sinopharm Group and Merck & Co., Inc. Sign Statement of Mutual Intent to Boost China Presence

NovImmune SA Eyes IPO After Licensing Deal With Roche's Genentech

Sanofi-Aventis (France) Asks U.S. Court to Block Sandoz, Inc.'s Generic Blood Thinner

Sanofi-Aventis (France) Alnwick Site Sale May Fund US Bid; 150 Jobs Secured

Remembering To Forget: The Amnesic Effect Of Daydreaming, University of North Carolina And Florida State University Study

Prolias LLC Spins Out Prolias Technologies, Inc., a Life Sciences Research Reagent Supplier to the Cancer Research Community

Great Lakes Pharmaceuticals, Inc. Raises $3.1 Million

Ampio Pharmaceuticals, Inc. Announces Acquisition of DMI BioSciences, Inc.

Appeal Ruling Forces Rethink on Celgene's Vidaza for MDS

Diex Research Grows into Montreal; Expects to Hire 10-20 Employees Within Next Year

Sanofi-Aventis (France) and Merck & Co., Inc. Appoint as CEO for the New Animal Health Joint Venture

Novartis Corporation Q2 Prompts Fresh Call for Higher Alcon, Inc. Bid

New Compound Improves Obesity-Related Health Complications, National Institutes of Health (NIH) Study

Commonwealth Biotechnologies, Inc. Announces Appointment of as Chief Executive Officer

Teva Pharmaceutical Industries Limited Q2 Profit Beats Estimates, Sales in Line

Muscle Gene May Provide New Treatments for Obesity And Diabetes, Rockefeller University Study

Infectious Prions Can Arise Spontaneously in Normal Brain Tissue, The Scripps Research Institute And University College London Study Shows

Antares Pharma, Inc. Announces Positive Top Line Results From Its Pivotal Phase 3 Study of Anturol Gel for the Treatment of Overactive Bladder

PSA Screening Leads To Overdiagnosis, Often Aggressive Follow-Up, Cancer Institute of New Jersey Study

Concern Over Animal Molecule In Drugs, University of California, San Diego (UCSD) Study

Onyx Pharmaceuticals, Inc. Announces Positive Top-Line Carfilzomib Data From Phase 2b Study

Pre-Exposure Prophylaxis Against HIV Found Safe, Centers for Disease Control and Prevention (CDC) Study

Certain Epilepsy Drugs May Increase Risk of Suicide, Charite Medicine University Study

Dangers of Untreated Erectile Dysfunction, Study

Nasal Spray Vaccine for Meningitis In Pipeline, University of Liverpool Study

Ambit Biosciences Announces as Chairman and Chief Executive Officer

Immune Design Corporation Raises $32 Million in Series B Financing

Irradiating Stem Cell Niche Doubles Survival in Brain Cancer Patients, University of California, Los Angeles (UCLA) Study

Rare And Common Genetic Variations Responsible For High Triglyceride Levels In Blood, University of Western Ontario Study

Dr. Reddy's Laboratories Ltd.'s Rules Out Stake Sale to GlaxoSmithKline

Returning Drugs Giant GlaxoSmithKline To Good Health

Gilead Sciences, Inc. to Offer $2.2 Billion of Convertible Senior Notes; Company to Repurchase $1 Billion in Common Stock

XOMA (US) LLC Receives $750,000 Milestone Payment From AVEO Pharmaceuticals, Inc.

FDA Grants Biovest International, Inc. Orphan Drug Status for Personalized Cancer Vaccine, BiovaxID(R), Targeting Mantle Cell Lymphoma

National Institutes of Health (NIH) Develops Projects to Fight Rare Diseases

FDA Approves Daiichi Sankyo, Inc.'s Tribenzor, A New Three-In-One Combination Product for the Treatment of High Blood Pressure

Cerenis Therapeutics, Inc. Raises $51.7 Million in Series C Financing and Wins $13.8 Million from French Government

New National Institutes of Health (NIH) Grants Could Make Washington Hot Spot For Clinical Research

Johnson & Johnson's HIV Drug Rilpivirine Passes Phase III Trials but Stumbles on Virologic Failure

Eisai Inc. and Pfizer Inc. Announce U.S. FDA Approval for New Higher-Dose Aricept(R) (donepezil HCl) 23 mg Tablet for the Treatment of Moderate-to-Severe Alzheimer's Disease

FDA Panel Opposes Plan to Tighten Use of Painkillers

Sitting, Even After Workout, Can Cut Lifespan, American Cancer Society Study

Gene May Hold Key to Reducing Spread of Oral Cancers, University of Illinois Study

Momenta Pharmaceuticals, Inc. Announces FDA Approval for First Generic Lovenox(R); Shares Surge

'Sleep Control' Cells Allow Blind Mice To See, Johns Hopkins University Study

Sickle Cell Treatment Developed At LA BioMed Enters Phase 3 Clinical Trial

Pfizer Animal Health Recalls Animal Drug, Terramycin

Single Gene Could Be Key To A Baby's First Breath, CNRS - Facult?? de M??decine Study

Gene Curtails Alzheimer's In Mice, Massachusetts Institute of Technology (MIT) Study

Scientists Confirm Role for Mysterious Cell Component - The Nucleolinus, University of Illinois Study

PRA International, Inc. to Hire 100 to 150 Clinical Research Associates and Project Managers

Heart Risk Factors Less Common In Fish Lovers, Study

Meda AB Receives One-Time Payment of 45 Million EUR from Almirall

Elan Corporation PLC CEO Is Inept, Misleading & Should Go, Investor Says

Emisphere Technologies, Inc., Novartis Pharma AG. Nordic Bioscience A/S Provide Update on Osteoarthritis Phase III Study With Oral Calcitonin; Drug Deemed Safe But Not Effective, Stock Falls 61.15% at 1:37PM EDT

Datamonitor Report: Roche/Genentech's Avastin Faces Breast Cancer Setback But Will Likely Retain Leading Position In Oncology

Use of Cephalon, Inc.'s Provigil Could be Limited in Europe

Roche Holding AG Profit Rises 58% on Lower Integration Costs

Tibotec Pharmaceuticals Ltd Announces TMC278 Pivotal Phase 3 Clinical Trials Achieve Primary Objective

Cialis' Success Fuels Eli Lilly and Company Push for New Men's Health Drugs

Researchers Find Link Between Childhood Physical Abuse And Heart Disease, University of Toronto Study

Louisville's GlobeImmune, Inc. Cuts Staff by 25 Percent

Forest Laboratories, Inc., Merz Pharma GmbH & Co. KGaA Settle Patent Dispute Over Namenda

FTC Denies Sharing Confidential Information in Watson Pharmaceuticals, Inc. Spat

Federal Government Seizes Cyanide Antidote Kits From California Company, Keystone Pharmaceuticals, Inc.

Abnormal Cells in Blood Tied to Lung Cancer: Circulating Aberrant Cells Increase as Non-Small Cell Lung Cancer Progresses, University of Texas Health Science Center Study

Horizon Pharma, Inc. Announces Results of Phase 3 Study of LODOTRA(R) Demonstrate 12-Month Sustained Efficacy and Safety in Rheumatoid Arthritis

Upcoming Events

    Read more..
Related Links

    Read more..
Search
Search :